Literature DB >> 29516021

Hypertension Among Persons Living With HIV in Medical Care in the United States-Medical Monitoring Project, 2013-2014.

Oluwatosin Olaiya1, John Weiser1, Wen Zhou2, Pragna Patel3, Heather Bradley1.   

Abstract

Hypertension is a leading modifiable risk factor for cardiovascular disease (CVD), and persons living with HIV are at increased risk for both hypertension and CVD. Therefore, using data from a nationally representative sample of patients living with HIV, we assessed missed opportunities for the optimal management of hypertension.

Entities:  

Keywords:  HIV; Medical Monitoring Project; cardiovascular disease; hypertension; prevalence

Year:  2018        PMID： 29516021      PMCID： PMC5833317          DOI： 10.1093/ofid/ofy028

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  11 in total

1.  HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.

Authors:  Sylvie Lang; Murielle Mary-Krause; Anne Simon; Marialuisa Partisani; Jacques Gilquin; Laurent Cotte; Franck Boccara; Dominique Costagliola
Journal:  Clin Infect Dis       Date:  2012-05-18       Impact factor: 9.079

2.  Hypertension in HIV-infected patients: prevalence and related factors.

Authors:  Carlos Jericó; Hernando Knobel; Milagro Montero; María L Sorli; Ana Guelar; Juan L Gimeno; Pere Saballs; Jose L López-Colomés; Juan Pedro-Botet
Journal:  Am J Hypertens       Date:  2005-11       Impact factor: 2.689

3.  Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Authors:  Colette J Smith; Lene Ryom; Rainer Weber; Philippe Morlat; Christian Pradier; Peter Reiss; Justyna D Kowalska; Stephane de Wit; Matthew Law; Wafaa el Sadr; Ole Kirk; Nina Friis-Moller; Antonella d'Arminio Monforte; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren
Journal:  Lancet       Date:  2014-07-19       Impact factor: 79.321

4.  Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.

Authors:  Morten Baekken; Ingrid Os; Leiv Sandvik; Olav Oektedalen
Journal:  J Hypertens       Date:  2008-11       Impact factor: 4.844

5.  Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.

Authors:  Heather Bradley; Christine L Mattson; Linda Beer; Ping Huang; R Luke Shouse
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

6.  Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.

Authors:  Carmine Gazzaruso; Raffaele Bruno; Adriana Garzaniti; Stefano Giordanetti; Pietro Fratino; Paolo Sacchi; Gaetano Filice
Journal:  J Hypertens       Date:  2003-07       Impact factor: 4.844

7.  Hypertension Prevalence and Control Among Adults: United States, 2011-2014.

Authors:  Sung Sug Sarah Yoon; Margaret D Carroll; Cheryl D Fryar
Journal:  NCHS Data Brief       Date:  2015-11

8.  Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013.

Authors:  Matthew J Feinstein; Ehete Bahiru; Chad Achenbach; Christopher T Longenecker; Priscilla Hsue; Kaku So-Armah; Matthew S Freiberg; Donald M Lloyd-Jones
Journal:  Am J Cardiol       Date:  2015-11-06       Impact factor: 2.778

9.  Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Authors:  Rodolphe Thiébaut; Wafaa M El-Sadr; Nina Friis-Møller; Martin Rickenbach; Peter Reiss; Antonella D'Arminio Monforte; Linda Morfeldt; Eric Fontas; Ole Kirk; Stephane De Wit; Gonzalo Calvo; Matthew G Law; François Dabis; Caroline A Sabin; Jens D Lundgren
Journal:  Antivir Ther       Date:  2005

10.  Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data.

Authors:  Tiarney D Ritchwood; Kinfe G Bishu; Leonard E Egede
Journal:  Int J Equity Health       Date:  2017-10-27
View more
  6 in total

1.  Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV.

Authors:  Mohammed Siddiqui; T J Moore; Dustin M Long; Greer A Burkholder; Amanda Willig; Christina Wyatt; Sonya Heath; Paul Muntner; Edgar Turner Overton
Journal:  AIDS Res Hum Retroviruses       Date:  2022-08-23       Impact factor: 1.723

Review 2.  Harm reduction for smokers living with HIV.

Authors:  Jonathan Shuter; Krishna P Reddy; Emily P Hyle; Cassandra A Stanton; Nancy A Rigotti
Journal:  Lancet HIV       Date:  2021-08-27       Impact factor: 16.070

3.  Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors.

Authors:  Yen-Wen Chen; Helene Hardy; Christopher D Pericone; Wing Chow
Journal:  J Health Econ Outcomes Res       Date:  2020-07-16

Review 4.  A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.

Authors:  Allison R Webel; Julie Schexnayder; Patricia A Cioe; Julie A Zuñiga
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

5.  Time to hypertension development among people living with HIV in South Africa: A longitudinal analysis of the National Income Dynamics Survey (NIDS).

Authors:  Motlatso Godongwana; Nicole De Wet-Billings
Journal:  Heliyon       Date:  2021-08-09

6.  Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors.

Authors:  Yen-Wen Chen; David Anderson; Christopher D Pericone; Prina Donga
Journal:  J Health Econ Outcomes Res       Date:  2022-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.